CCMIC
DFTX

Cardinal Capital Management Inc (Canada)’s Definium Therapeutics DFTX Stock Holding History

Cardinal Capital Management Inc (Canada)’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-250
Closed -$5K – 98
2021
Q4 		$5K Buy
+250
New +$7.98K ﹤0.01% 77

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCI
Data Collective IV Palo Alto, California $78.6M AUM 55.41% 1-Year Est. Return
BB
Busey Bank Urbana, Illinois $4.12B AUM 32.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return

Cardinal Capital Management Inc (Canada)'s DFTX Position: Q1 2022 in Review

Cardinal Capital Management Inc (Canada) sold out of Definium Therapeutics (DFTX) in Q1 2022, closing a stake of 250 shares — an estimated $5K sold.

Cardinal Capital Management Inc (Canada) first reported a position in DFTX in Q4 2021 and held it in 1 quarter. The position peaked at $5K in Q4 2021. 159 funds tracked by Wall St. Rank hold DFTX as of Q1 2022.

  • Cardinal Capital Management Inc (Canada) reported no remaining Definium Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Cardinal Capital Management Inc (Canada) sold 250 Definium Therapeutics shares in Q1 2022, an estimated $5K.
  • Cardinal Capital Management Inc (Canada) first reported a position in Definium Therapeutics in Q4 2021 and held it in 1 quarter.
  • Cardinal Capital Management Inc (Canada)'s Definium Therapeutics position peaked at $5K in Q4 2021.
  • 159 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2022.

Based on Cardinal Capital Management Inc (Canada)'s 13F filing for Q1 2022, filed 12 Apr 2022.